4.6 Article

Abstract C62: Identification of GSK2126458, a highly potent inhibitor of phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR)

Journal

MOLECULAR CANCER THERAPEUTICS
Volume 8, Issue Supplement 1, Pages C62-C62

Publisher

American Association for Cancer Research (AACR)
DOI: 10.1158/1535-7163.targ-09-c62

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available